Latest Ratios: P/E Ratio 41.7x · EV/EBITDA 12.3x · ROE 10.4%. (2023–2025 historical series)
Price-based multiples — how expensive the stock is relative to earnings, sales, book value, and cash flow
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 |
|---|---|---|---|---|
| Market Cap | $9.9B | $7.7B | — | — |
| Enterprise Value | $11.8B | $9.6B | — | — |
| P/E Ratio → | 41.68 | 32.60 | — | — |
| P/S Ratio | 2.54 | 1.99 | — | — |
| P/B Ratio | 7.17 | 5.61 | — | — |
| P/FCF | — | — | — | — |
| P/OCF | — | — | — | — |
P/E links to full P/E history page with 30-year chart
Enterprise-value multiples — capital-structure-neutral measures of total business value
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 |
|---|---|---|---|---|
| EV / Revenue | — | 2.47 | — | — |
| EV / EBITDA | 12.33 | 10.08 | — | — |
| EV / EBIT | 16.06 | 13.13 | — | — |
| EV / FCF | — | — | — | — |
Margins and return-on-capital ratios measuring operating efficiency
Full margin charts and quarterly trend are on the Earnings History page
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 |
|---|---|---|---|---|
| Gross Margin | 32.2% | 32.2% | 34.4% | 35.2% |
| Operating Margin | 18.8% | 18.8% | 20.2% | 22.6% |
| Net Profit Margin | 6.1% | 6.1% | 11.2% | 17.0% |
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 |
|---|---|---|---|---|
| ROE | 10.4% | 10.4% | 13.6% | 20.5% |
| ROA | 4.4% | 4.4% | 8.7% | 13.3% |
| ROIC | 14.8% | 14.8% | 16.6% | 19.0% |
| ROCE | 18.6% | 18.6% | 20.4% | 23.3% |
Solvency and debt-coverage ratios — lower is generally safer
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 |
|---|---|---|---|---|
| Debt / Equity | 1.76 | 1.76 | 0.13 | 0.08 |
| Debt / EBITDA | 2.54 | 2.54 | 0.43 | 0.22 |
| Net Debt / Equity | — | 1.37 | -0.08 | -0.12 |
| Net Debt / EBITDA | 1.98 | 1.98 | -0.25 | -0.36 |
| Debt / FCF | — | — | -0.45 | -0.82 |
| Interest Coverage | 26.14 | 26.14 | 5.03 | 51.88 |
Short-term solvency ratios and asset-utilisation metrics
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 |
|---|---|---|---|---|
| Current Ratio | 1.39 | 1.39 | 1.72 | 1.66 |
| Quick Ratio | 1.39 | 1.39 | 1.72 | 1.66 |
| Cash Ratio | 0.31 | 0.31 | 0.61 | 0.54 |
| Asset Turnover | — | 0.68 | 0.75 | 0.78 |
| Inventory Turnover | — | — | — | — |
| Days Sales Outstanding | — | — | — | — |
Earnings, FCF, buyback, and dividend yields — total returns to shareholders
Full dividend history and growth charts are on the Dividend History page
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 |
|---|---|---|---|---|
| Dividend Yield | — | — | — | — |
| Payout Ratio | — | — | — | — |
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 |
|---|---|---|---|---|
| Earnings Yield | 2.4% | 3.1% | — | — |
| FCF Yield | — | — | — | — |
| Buyback Yield | 0.0% | — | — | — |
| Total Shareholder Yield | 0.0% | — | — | — |
| Shares Outstanding | — | $159M | $159M | $159M |
Regulatory PFAS litigation exposure
Based on reported figures, SOLS trades at a forward P/E of 31.17, which suggests that investors are pricing in significant growth from the HFC phase-down transition, despite the company's modest 3.08% year-over-year revenue growth and the inherent cyclicality of its specialty chemical manufacturing business model.
The current valuation appears to command a premium relative to traditional industrial peers, likely reflecting the market's perception of SOLS as a regulatory-capture play rather than a standard chemical producer. However, the lack of a clear PEG ratio and the high TTM P/E of 55.50 suggest that current earnings are depressed by non-recurring items or heavy investment, warranting caution regarding the sustainability of this multiple.
According to historical financial data, SOLS has struggled to maintain consistent returns, with ROIC fluctuating between 2.4% and 4.5% over the last ten quarters, indicating that the company's heavy investment in specialized synthesis infrastructure has yet to yield the compounding returns expected of a specialty chemical leader.
The low ROIC relative to the cost of capital suggests that the company is currently in a capital-intensive phase where asset turnover remains low at approximately 0.17x. Investors should monitor whether the recent expansion into data center cooling applications can drive higher asset utilization and improve these returns over the medium term.
As reported in recent quarterly filings, the company's efficiency metrics show significant variability, with DSO fluctuating between 57 and 72 days, which suggests that SOLS faces challenges in optimizing its cash conversion cycle amidst shifting demand patterns in the HVAC and semiconductor supply chains.
The lack of consistent data for DIO and DPO makes a full CCC analysis difficult, but the observed volatility in DSO implies that customer payment terms may be under pressure or that the sales mix is shifting toward segments with longer collection cycles. This inconsistency in working capital management may continue to create noise in the company's free cash flow generation.
Based on the provided balance sheet data, SOLS has seen its debt-to-equity ratio climb from 0.13 in 2024Q4 to 1.76 in 2026Q1, signaling a marked shift toward a more levered capital structure that may limit future operational flexibility if cash flow generation remains inconsistent.
While the company previously maintained a fortress-like balance sheet, the rapid accumulation of debt to $2.4 billion suggests a strategic pivot that warrants close monitoring. The interest coverage ratio has also become increasingly volatile, dropping from 146.33 in 2025Q1 to 6.21 in 2026Q1, which indicates that debt service is becoming a more material consideration for the firm.
The P/E ratio is frequently misapplied to SOLS, as it obscures the impact of significant non-operating expenses and environmental remediation costs that distort net income, making the EV/EBITDA multiple a more reliable metric for assessing the underlying earning power of this capital-intensive specialty chemical business.
Because SOLS operates with high fixed costs and significant regulatory-related accounting adjustments, the net income line is often noisy and unrepresentative of core operational performance. Analysts should prioritize EV/EBITDA to normalize for capital structure changes and focus on cash-based metrics to better understand the company's ability to fund its ongoing R&D and infrastructure requirements.
Includes 30+ ratios · 3 years · Updated daily
DCF models, multiple analysis, and analyst estimates.
10-year return with dividends reinvested.
See how regular investing compounds over time.
Compare growth, multiples, and margins vs sector.
Quick answers to the most common questions about buying SOLS stock.
Solstice Advanced Materials Inc.'s current P/E ratio is 41.7x. The historical average is 32.6x. This places it at the 100th percentile of its historical range.
Solstice Advanced Materials Inc.'s current EV/EBITDA is 12.3x. This enterprise value multiple compares the company's total value (equity + debt - cash) to its EBITDA. The historical average is 10.1x.
Solstice Advanced Materials Inc.'s return on equity (ROE) is 10.4%. The historical average is 14.8%.
Based on historical data, Solstice Advanced Materials Inc. is trading at a P/E of 41.7x. This is at the 100th percentile of its historical P/E range. Compare with industry peers and growth rates for a complete picture.
Solstice Advanced Materials Inc. has 32.2% gross margin and 18.8% operating margin. Operating margin between 10-20% is typical for established companies.
Solstice Advanced Materials Inc.'s Debt/EBITDA ratio is 2.5x, indicating moderate leverage. A ratio between 2-4x is manageable but warrants monitoring.